News
Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side effects.
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
With their lengthening laundry list of health benefits, drugs like Ozempic are showing promise for people who struggle with addiction.
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...
Among employers with 500 or more workers, 51% said they planned to increase cost-sharing in 2026, including raising deductibles and maximum out-of-pocket costs for workers ...
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results